Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

<div><p>With the advent of the genetic era in Parkinson’s disease (PD) research in 1997, α-synuclein was identified as an important player in a complex neurodegenerative disease that affects >10 million people worldwide. PD has been estimated to have an economic impact of $51.9 billio...

وصف كامل

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Luis M. A. Oliveira (18459000) (author)
مؤلفون آخرون:	Thomas Gasser (33499) (author), Robert Edwards (1230) (author), Markus Zweckstetter (133481) (author), Ronald Melki (102380) (author), Leonidas Stefanis (264252) (author), Hilal A. Lashuel (261037) (author), David Sulzer (86849) (author), Kostas Vekrellis (214282) (author), Glenda M. Halliday (11232982) (author), Julianna J. Tomlinson (15257035) (author), Michael Schlossmacher (4377472) (author), Poul Henning Jensen (7490708) (author), Julia Schulze-Hentrich (18459003) (author), Olaf Riess (110686) (author), Warren D. Hirst (238891) (author), Omar El-Agnaf (2134222) (author), Brit Mollenhauer (482499) (author), Peter Lansbury (5154518) (author), Tiago F. Outeiro (191379) (author)
منشور في:	2021
الموضوعات:	Biomedical and clinical sciences Neurosciences Parkinson’s disease (PD) α-synuclein Genetic era Neurodegenerative disease Epidemiology Economic impact Research Functions
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

كن أول من يترك تعليقا!

Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

مواد مشابهة